Indoco Remedies surges as company's Goa plant receives USFDA go ahead

NEW DELHI: Shares of Indoco Remedies ends higher by 11 per cent after the company received US Food and Drug Administration for its Goa unit.

Reacting to the development, the scrip gained 17.45 per cent to hit a high of Rs 314. The stock has slipped 7 per cent in the year so far.

It has a manufacturing capacity of 2.2 billion tablets, 32 million bottles of liquid orals, 16 million tubes of creams and ointments and 60 million capsules of hard gelatin.